Quick Quiz - 2024 Optometry Seminar - Hunter Street Eye Specialists

Attendees name

First Last

OA Number

Quiz Section 1 : DRY EYE MANAGEMENT: WHAT’S COMING IN 2024

1. Which clinical indicators are helpful in assessing dry eye syndrome?(Required)

A. Tear film break up time (TBUT)

B. Schirmer’s test

C. Meibomian gland assessment

D. All of the above

2. Currently, what is the most common type of dry eye?(Required)

A. Evaporative/dysfunctional

B. Deficiency

C. Combination of A and B

D. Related to medication use

3. Rosacea is:(Required)

A. A common cause of blepharitis and dry eyes

B. A systemic autoinflammatory disease

C. Genetic basis: patients are born with the disease

D. All of the above

4. What is not typical of Rosacea related DES?(Required)

A. Blepharitis

B. Lid margin telangiectasia

C. Rapid TBUT

D. Follicular conjunctivitis

5. Emerging/Novel treatments for DED include:(Required)

A. IPL

B. Diet modification

C. Inflammation targeting topical and systemic medications

D. All of the above

Quiz Section 2: MULTIFOCAL IOLS, MONOVISION, AND EDOF: ONLY 2 CAN SURVIVE

1. What are the distinguishing features of emerging EDOF (Extended Depth of Focus) intraocular lenses compared to traditional multifocal IOLs?(Required)

A. Continuous range of vision

B. Reduced risk of halos and glare

C. Enhanced contrast sensitivity

D. Less Range of vision

E. All of the above

2. How do EDOF lenses differ from traditional multifocal lenses in terms of optical design?(Required)

A. EDOF lenses utilize diffractive optics

B. EDOF lenses employ extended depth of focus technology

C. EDOF lenses have multiple distinct focal points

D. All of the above

3. Arrow on the image above indicates “what” on the toric IOL?(Required)

A. Indicates IOL Branding

B. Indicates IOL Haptics

C. Indicates Toric Axis markers for orientation

D. Indicates focal point of IOL power

4. How do EDOF IOLs minimize the induction of halos compared to multifocal IOLs?(Required)

A. By presenting a flat spot for sharp vision at one meter distance

B. By inducing glare around bright sources of light

C. By creating a smoother continuum of light distribution without diffractive optics

D. By providing multiple focal points simultaneously to the retina

5. Which strategy is possible to compensate for near visual acuity insufficiency after EDOF implantation?(Required)

A. Using reading glasses

B. Undergoing additional laser eye surgery

C. Wearing contact lenses

D. Any of above

Quiz Section 3: NON-IOP GLAUCOMA RISK FACTORS & MANAGEMENT: WHAT IS THE EVIDENCE?

1. Evidence that Glaucoma may a neurodegeneration with metabolic dysfunction include all but:(Required)

A. Association with other neurodegenerative diseases such as Alzheimer’s disease

B. Association with other metabolic diseases such as diabetes

C. Association with high baseline metabolic rate

D. The known high metabolic demands of retinal ganglion cells/retinal nerve fibres

2. Which of the following is true?(Required)

A. Obstructive sleep apnoea is not a risk factor for glaucoma

B. Obstructive sleep apnoea is a risk factor for glaucoma

C. CPAP elevates intraocular pressure

D. CPAP lowers intraocular pressure

3. Regarding diet and supplements and glaucoma:(Required)

A. Gingko biloba has shown some efficacy in studies

B. Vitamin B3 is being trialled in humans

C. Caffeine and alcohol effect is inconclusive

D. All of the Above

4. With Exercise and glaucoma:(Required)

A. It can lower intraocular pressure

B. Prolonged head down positions should be avoided

C. Prolonged breath holding or Valsalva should be avoided

D. Tight swimming goggles elevated intraocular pressure

E. All of the above

5. The Sight Score(Required)

A. Can definitively diagnose glaucoma in suspects

B. Can aid decision making about frequency of reviews in a glaucoma suspect

C. Should be performed in all people

D. Demonstrates that glaucoma is a genetic disease and environment has no impact

Quiz Section 4: COMBATING THE MYOPIA EPIDEMIC: EFFECTIVE STRATEGIES, PITFALLS, AND INNOVATIONS

1. Based on current literature, which of the below treatment modalities has shown to slow down myopia progression by 50% on average?(Required)

A. Executive bifocals

B. Highly Aspherical Lenslet Technology (HALT) spectacle lenses

C. Atropine 0.01%

D. Progressive spectacle lenses

2. A two-year randomised controlled trial with Stellest in 167 myopia children aged between 8-13 years found that compared with single vision lenses, children who wore Stellest full time had a reduced rate of myopia progression by:(Required)

A. 33%

B. 50%

C. 67%

D. 90%

3. An objective test to monitor myopia progression is:(Required)

A. Refraction

B. Ocular biometry

C. Accommodative facility

D. Visual Acuity

5. How can practitioners stay informed about the latest advancements and research in myopia management?(Required)

A. Attending conferences and workshops focused on myopia control

B. Engaging in online forums and professional networks

C. Subscribing to peer-reviewed journals publishing myopia research

D. All of the above

4. Which myopia control options provide vision correction at the same time?(Required)

A. Distance centred dual focus contact lenses

B. Orthokeratology

C. HALT spectacle lenses

D. All of the above

Comments

This field is for validation purposes and should be left unchanged.

Quick Quiz – 2024 Optometry Seminar

Have you been paying attention?

Quiz Section 1 : DRY EYE MANAGEMENT: WHAT’S COMING IN 2024

Quiz Section 2: MULTIFOCAL IOLS, MONOVISION, AND EDOF: ONLY 2 CAN SURVIVE

Quiz Section 3: NON-IOP GLAUCOMA RISK FACTORS & MANAGEMENT: WHAT IS THE EVIDENCE?

Quiz Section 4: COMBATING THE MYOPIA EPIDEMIC: EFFECTIVE STRATEGIES, PITFALLS, AND INNOVATIONS

Sponsored By